Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part II: A Cancer Risk Meta-Analysis

Clicks: 259
ID: 267485
2021
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Aberrant methylation of tumor suppressor genes has been reported as an important epigenetic silencer in head and neck cancer (HNC) pathogenesis. Here, we performed a comprehensive meta-analysis to evaluate the overall and specific impact of salivary gene promoter methylation on HNC risk. The methodological quality was assessed using the Newcastle–Ottawa scale (NOS). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to evaluate the strength of the association and Egger’s and Begg’s tests were applied to detect publication bias. The frequency of salivary DNA promoter methylation was significantly higher in HNC patients than in healthy controls (OR: 8.34 (95% CI = 6.10–11.39; p < 0.01). The pooled ORs showed a significant association between specific tumor-related genes and HNC risk: p16 (3.75; 95% CI = 2.51–5.60), MGMT (5.72; 95% CI = 3.00–10.91), DAPK (5.34; 95% CI = 2.18–13.10), TIMP3 (3.42; 95% CI = 1.99–5.88), and RASSF1A (7.69; 95% CI = 3.88–15.23). Overall, our meta-analysis provides precise evidence on the association between salivary DNA promoter hypermethylation and HNC risk. Thus, detection of promoter DNA methylation in saliva is a potential biomarker for predicting HNC risk.
Reference Key
rapado-gonzález2021journalsalivary Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Óscar Rapado-González;Cristina Martínez-Reglero;Ángel Salgado-Barreira;María Arminda Santos;Rafael López-López;Ángel Díaz-Lagares;María Mercedes Suárez-Cunqueiro;Rapado-González, Óscar;Martínez-Reglero, Cristina;Salgado-Barreira, Ángel;Santos, María Arminda;López-López, Rafael;Díaz-Lagares, Ángel;Suárez-Cunqueiro, María Mercedes;
Journal Journal of personalized medicine
Year 2021
DOI 10.3390/jpm11070606
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.